Dentis덴티스
261200 · KOSDAQ · ₩261200 · 덴티스
What brokers say about Dentis
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Dentis is loss-making on an operating basis in H1 2026 and its shares have fallen about 52% over the past year, with a stretched debt load.
Dentis sells dental implants, LED dental lights and 3D printers in South Korea and abroad. Trailing revenue to H1 2026 is about ₩111.7B, but operating income is about -₩5.4B and free cash flow is about -₩3.8B, while borrowings of ₩99.5B sit against cash of ₩3.0B. The share price is ₩2,410, near the lower part of its 52-week range of ₩2,125 to ₩5,100.
What stands out
- 2025 was a weak year: revenue was roughly flat at ₩114.2B, operating income swung to about -₩10.4B and net income was about -₩14.2B.
- Trailing net income is positive at about ₩1.4B, but this is well below the operating loss, so the profit picture depends on non-operating items the data does not explain.
- Liabilities are about 281% of equity and the company carries roughly ₩99.5B of borrowings, a high debt load relative to its cash.
- Valuation metrics look low on a P/E of 27 and P/B of 0.7, but the earnings base is volatile and the data gives no forecasts to judge whether this reflects value.
- Foreign ownership fell from 4.4% to 3.4% over about 60 days, and the 20-day flows show foreign buying alongside net retail selling.
What to watch
- Whether the company returns to positive operating income in its next reported results, given the H1 2026 operating loss.
- Filings on the disclosure-compliance designation: the company was named an unfaithful disclosure company in September 2026 and was then not designated after a deferred review in October.
- Ongoing shareholder changes and convertible bond activity, which the recent filings show, and any effect on dilution or control.
Data as of Oct 23, 2026 · written 4d ago
This is not financial advice.
Also known as: Dentis / 덴티스 / 261200 / KRX:261200
Source: KRX statistical information